L'intérêt à découvert pour GDS Holdings donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de GDS Holdings. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

GDS Holdings (NASDAQ:GDS) Stock, Rapport sur les intérêts à découvert

GDS HOLDINGS LTD - ADR

GDS Holdings

GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

WIIM

LVLU

Lulu's Fashion Lounge Holdings shares are trading higher after the company announced it regained compliance with the Nasdaq.

PHVS

Pharvaris shares are trading lower after the company announced a $150 million proposed public offering.

Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported financial results for the second quarter after the market close on Tuesday. Here&#8217;s a look at hey metrics <a href="https://www.benzinga.com/pressreleases/25/07/g46558462/intuitive-announces-second-quarter-earnings">from the quarter</a>.
Q2 Earnings: Intuitive Surgical reported second-quarter revenue of $2.44 billion, beating analyst&nbsp;<a href="http://benzinga.com/quote/isrg/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $2.35 billion, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The robotic-assisted surgery company reported second-quarter adjusted earnings of $2.19 per share, beating analyst estimates of $1.93 per share.
Total revenue was up 21% year-over-year as Worldwide da Vinci procedures increased approximately 17%. The company said it&nbsp;placed 395 da Vinci surgical systems in the quarter, versus 341 in the prior year's quarter. Intuitive Surgical's da Vinci surgical system installed base grew to 10,488 systems as of June 30, up 14% year-over-year.
Intuitive Surgical ended the quarter with $9.53 billion in cash, cash equivalents and investments, up $431 million from the first quarter.
&#8220;We&#8217;re pleased with our solid performance this quarter, highlighted by continued customer adoption of our newer and existing platforms, including da Vinci 5,&#8221; stated Dave Rosa, CEO of Intuitive Surgical.
&#8220;We are committed to advancing care, and helping our customers provide better patient outcomes, better patient and care team experiences, broadening access to care and decreasing the total cost of care.&#8221;
Outlook: Intuitive Surgical expects full-year 2025 worldwide da Vinci procedures to increase approximately&nbsp;15.5%&nbsp;to&nbsp;17%. The company expects gross profit margin to be between&nbsp;66%&nbsp;and&nbsp;67%&nbsp;of revenue in 2025, which includes an estimated 1% impact from tariffs.
Company executives are set to further discuss the quarter on a call with investors and analysts at 4:30 p.m. ET.
ISRG Price Action: <a href="http://benzinga.com/quote/isrg" target="_blank" rel="noreferrer noopener">Intuitive Surgical shares</a> were down 4.11% in after-hours, trading at $490 at the time of publication Tuesday, according to data from <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46552653/wall-street-today-markets-tuesday-lockheed-general-motors-gold-price-dollar">Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What&#8217;s Moving Markets Tuesday?</a></li>
</ul>
Photo: Shutterstock.

Earnings

News

Guidance

Health Care

After-Hours Center

Movers

ISRG

Intuitive Surgical Beats Q2 Earnings Estimates As Revenue Jumps 21%, Shares Slide

VICR

Vicor shares are trading lower. The company reported Q2 financial results.

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported quarterly earnings of $7.04 per share which beat the analyst consensus estimate of $4.23 by 66.31 percent. This is a 203.45 percent increase over earnings of $2.32 per share from the same period last year. The company reported quarterly sales of $1.10 million which missed the analyst consensus estimate of $877.03 million by 99.87 percent. This is a 99.83 percent decrease over sales of $640.79 million the same period last year.

Earnings Beats

Earnings Misses

CALM

Cal-Maine Foods Q4 EPS $7.04 Beats $4.23 Estimate, Sales $1.10M Miss $877.03M Estimate

MANH

Manhattan Associates shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance above estimates.

N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.
Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of an exozyme biosolution - has been developed: Progressing from concept to lab scale validation with gram-scale production in only 5 months and at a fraction of normal SynBio R&amp;D cost.
<a href="https://www.nctx.one/">NCTx</a> was created as a spin-out company to commercialize the NCT technology and is now able to provide early access partners, under material transfer agreement with product samples. NCTx and eXoZymes are <a href="https://exozymes.com/partner-to-be">actively looking to increase the number of partners</a>.
LOS ANGELES, CALIFORNIA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / July 22, 2025 / Today, eXoZymes Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/EXOZ#NASDAQ">EXOZ</a>) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - together with its spinout <a href="https://pr.report/cjnn">NCTx</a>, announced a breakthrough in biomanufacturing using their cell-free exozyme platform: From proof-of-concept to lab scale validation with gram-scale production in only 5 months.
This critical technical milestone validates the exozyme biosolution process design for NCT, enabling it to overcome a longstanding bottleneck in sourcing the NCT compound from nature, where it occurs only in trace amounts. Naturally found in quantities less than 0.014% per hemp seed, NCT has not been available at commercially viable qualities and quantities, severely limiting its otherwise immense market potential.
Successful completion of this milestone enables eXoZymes' team to initiate a comprehensive assessment of the purity profile. Separately, data collected on process-related parameters provides foundational de-risking information for the biomanufacturing economic assumptions and allows eXoZymes to <a href="https://pr.report/cjno">expand the number of early access partners</a>.

Biotech

General

EXOZ

eXoZymes And Spinout NCTx Achieve Breakthrough In Rapid, Scalable Biomanufacturing Of Rare Compound NCT Using AI-Driven Exozyme Platform

KKR Real Estate Finance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.01) by 400 percent. This is a 97.45 percent increase over losses of $(1.57) per share from the same period last year. The company reported quarterly sales of $30.171 million which missed the analyst consensus estimate of $32.367 million by 6.78 percent. This is a 25.38 percent decrease over sales of $40.433 million the same period last year.

KREF

KKR Real Estate Finance Q2 Adj. EPS $(0.04) Misses $(0.01) Estimate, Sales $30.171M Miss $32.367M Estimate

SAP shares are trading lower. The company reported Q2 financial results.

Canadian National Railway (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNR#TSX">CNR</a>) Adj eps CAD $1.87 Up from CAD $1.84 YoY; Revenue CAD $4.272B Down from CAD $4.329B YoY &nbsp;

TSX:CNR

Canadian National Railway Q2 Adj eps CAD $1.87 Up from CAD $1.84 YoY; Revenue CAD $4.272B Down from CAD $4.329B YoY

PennyMac Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMT#NYSE">PMT</a>) reported quarterly losses of $(0.04) per share. This is a 123.53 percent decrease over earnings of $0.17 per share from the same period last year. The company reported $70.201 million in sales this quarter. This is a 1.40 percent decrease over sales of $71.198 million the same period last year.

PennyMac Mortgage Q2 2025 GAAP EPS $(0.04) Down From $0.17 YoY, Net investment income $70.201M Down From $71.198M YoY

Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.67 by 1.35 percent. This is a 43.48 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $732.891 million which beat the analyst consensus estimate of $721.754 million by 1.54 percent. This is a 14.28 percent increase over sales of $641.292 million the same period last year.

Range Resources Q2 Adj. EPS $0.66 Misses $0.67 Estimate, Sales $732.891M Beat $721.754M Estimate

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) reported quarterly earnings of $2.28 per share which beat the analyst consensus estimate of $2.24 by 1.97 percent. This is a 10.14 percent increase over earnings of $2.07 per share from the same period last year. The company reported quarterly sales of $703.00 million which beat the analyst consensus estimate of $611.02 million by 15.05 percent. This is a 27.07 percent increase over sales of $553.23 million the same period last year.

EWBC

East West Bancorp Q2 Adj. EPS $2.28 Beats $2.24 Estimate, Sales $703.00M Beat $611.02M Estimate

Management

Georgia Power Appoints Tyler Cook CFO , Effective July 31, 2025

Community Health Systems, Inc. (Company) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 million cash.
When the transaction is complete, CHS patients and providers will benefit from broader access to Labcorp's comprehensive testing and laboratory services, including its specialty testing menu, robust data analytics and digital tools. CHS health systems will continue to operate their inpatient and emergency department laboratories and will continue to provide laboratory services for hospital-based services, such as imaging and pre-admission testing.
"We are excited about this transaction with Labcorp, which allows us to focus on our core services and improve the overall patient experience, aligning with our unwavering commitment to providing high-quality, accessible healthcare to our communities," said Kevin Stockton, Executive Vice President, Operations and Development for CHS. "Labcorp's scale and investment in technology supports its ability to efficiently deliver outreach laboratory services to patients and healthcare consumers."
"Labcorp and Community Health Systems share a deep commitment to improving the health and lives of the communities we serve, and our goal with this agreement is to enhance the patient and provider experience with increased access to high-quality laboratory services," added Mark Schroeder, EVP and President, Diagnostics Laboratories and Chief Operations Officer, Labcorp. "This acquisition will allow us to leverage the strengths of both our organizations to positively impact healthcare for communities across the U.S."
The organizations are committed to working together to plan and implement a smooth, thoughtful transition that maintains continuity of services for patients, hospitals, clinicians and clients, while providing direct access to the additional capabilities of Labcorp.
This relationship is similar to other strategic relationships that Labcorp has with a range of local and regional health systems that have enhanced services for patients and providers.
The transaction is subject to customary closing conditions and applicable regulatory approvals. The companies anticipate closing the transaction in the fourth quarter of 2025. Until that time, there will be no changes in operations or services.

Laboratory Corporation Of America Holdings

Community Health Systems' Subsidiary, CHS/Community Health Systems, And Labcorp Enter Into A Definitive Agreement; Labcorp To Acquire Select Assets And Assume Certain Leases Of The Ambulatory Outreach Laboratory Services Of CHS Health Systems In 13 States For $195M In Cash

Shares of server manufacturer Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) closed Tuesday&#8217;s session lower, caught in a broader pullback among chip and AI-related stocks. Here&#8217;s what investors <a href="https://www.benzinga.com/pressreleases/25/07/b46517663/supermicro-schedules-conference-call-and-webcast-for-fourth-quarter-and-fiscal-year-2025-financial">need to know</a>.
What To Know: The sector-wide pressure follows <a href="https://www.benzinga.com/markets/tech/25/07/46534661/500-billion-stumble-softbank-openais-massive-ai-vision-faces-setbacks">reports</a> that the high-profile &#8220;Stargate&#8221; AI venture is facing significant delays and scaled-back ambitions.
The $500 billion project, a joint initiative between SoftBank and OpenAI designed to massively expand U.S. AI infrastructure, has reportedly failed to secure any major data center deals six months after its announcement. 
According to The Wall Street Journal, <a href="https://www.benzinga.com/markets/tech/25/07/46534661/500-billion-stumble-softbank-openais-massive-ai-vision-faces-setbacks">persistent disputes</a> over strategy and control between SoftBank's Masayoshi Son and OpenAI's Sam Altman have crippled the project's momentum. Original plans for an immediate $100 billion investment have been shelved, with the focus now shifted to a much smaller facility in Ohio.
The Stargate slowdown is creating uncertainty around the timeline for massive AI hardware spending. While OpenAI has independently secured a major cloud capacity deal with Oracle, the struggles of its flagship infrastructure partnership are causing investors to temper near-term growth expectations. 
This has led to a sell-off in hardware suppliers like SMCI Tuesday afternoon, whose valuations are heavily dependent on the continued, rapid build-out of AI data centers.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, which assess stocks on four critical factors, SMCI demonstrates exceptional fundamental strength. The company earns its highest ratings for Quality with an outstanding score of 94.68, indicating a robust balance sheet and strong profitability. 
This is followed closely by an excellent Growth score of 86.99, pointing to strong historical and projected expansion. The stock also maintains solid Momentum with a score of 75.29, reflecting recent positive price performance. 
Its Value score is more moderate at 61.31, suggesting that while the stock is not considered overvalued, it may not be a deep bargain at its current price.
SMCI meanwhile has a 52-week high of $80.80 and a 52-week low of $17.25.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46553662/amd-stock-is-sliding-tuesday-whats-driving-the-action">AMD Stock Is Sliding Tuesday: What&#8217;s Driving The Action?</a>
<h2 class="wp-block-heading">How To Buy SMCI Stock</h2>
By now, you're likely curious about how to participate in the market for Super Micro Computer — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Super Micro Computer, which is trading at $49.99 at time of writing, $100 would buy you 2 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit off of the share price decline.
Image: Shutterstock

Tech

SMCI

What's Going On With Super Micro Computer Stock?

Macro Economic Events

Politics

Global

Economics

Reuters Cites White House Saying Trump Will Meet UK's Starmer During Weekend Trip; Trump, Starmer Will Seek To Formalize Trade Deal

Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, the USA and Israel, announced that on July 22, 2025, Ellomay Luzon Energy Infrastructures Ltd. ("Ellomay Luzon Energy"), an Israeli private company 50% held indirectly by the Company, completed the acquisition of 15% of the outstanding shares of Dorad Energy Ltd. ("Dorad"). As a result of the acquisition, Ellomay Luzon Energy holds 33.75% of Dorad's outstanding shares. &nbsp;
Ellomay Luzon Energy acquired 15% of Dorad's outstanding shares by exercising the right of first refusal granted to Ellomay Luzon Energy and other Dorad shareholders in connection with a sale of the shares by Zorlu Enerji Elektrik Üretim A.S ("Zorlu"), a former Dorad shareholder. In connection with the right of first refusal process, Ellomay Luzon Energy and Edelcom Ltd. ("Edelcom"), each executed an agreement to purchase 7.5% of Dorad's shares. As not all the conditions to closing of the sale of 7.5% of Dorad's shares to Edelcom were fulfilled, Edelcom's agreement was terminated and Ellomay Luzon Energy, who did succeed in fulfilling all of the conditions to closing, acquired 15% of Dorad's shares.
The consideration for the shares was approximately NIS 424 million (approximately €108 million), and was funded by bank financing (the "Loan Agreement") provided to Ellomay Luzon Energy consisting of three tranches as follows: (i) a loan in the amount of NIS 175 million (approximately €45 million), bearing annual interest in the range of +0.5% to -0.5% of the Israeli Prime Rate (the "First Loan"), (ii) a loan in the amount of NIS 175 million (approximately €45 million), bearing fixed annual interest rate between 5% and 6% (the "Second Loan"), and (iii) a loan in the amount of NIS 70 million (approximately €18 million), bearing annual interest rate in the range of +0.5% to -0.5% of the Israeli Prime Rate (the "Third Loan").
The First Loan is repayable in four semi-annual payments commencing December 31, 2031 and ending on June 30, 2033, and the interest on the First Loan is payable in semi-annual payments commencing December 31, 2025 and ending on the final repayment of the First Loan. The Second Loan is repayable in sixteen semi-annual payments commencing December 31, 2025 and ending on June 30, 2033, and the interest on the Second Loan is payable in semi-annual payment commencing December 31, 2025 and ending on the final repayment of the Second Loan. The Third Loan is repayable in one payment on December 31, 2025, unless the conditions set forth in the Loan Agreement will not be met, which will enable Ellomay Luzon Energy to ask for an extension until December 31, 2026. The interest on the Third Loan is payable on December 31, 2025 and, to the extent an extension is requested, in semi-annual payments thereafter until the final repayment of the Third Loan.

ELLO

Ellomay Capital Announces That It Completed The Acquisition Of 15% Of The Outstanding Shares Of Dorad Energy

Dividends

CBFV

CB Financial Services Increases Quarterly Dividend From $0.25 To $0.26 Per Share

CB Financial Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBFV#NASDAQ">CBFV</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.42 by 77.88 percent. This is a 42.31 percent increase over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $13.528 million which beat the analyst consensus estimate of $12.793 million by 5.75 percent. This is a 11.27 percent increase over sales of $12.158 million the same period last year.

CB Financial Services Q2 Adj. EPS $0.74 Beats $0.42 Estimate, Sales $13.528M Beat $12.793M Estimate

Markets

Press Releases

GDS Prices Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs

IPOs

GDS Announces Pricing of Public Offering of ADSs

GDS Announces Closing of Public Offering of ADSs and Full Exercise of Option to Purchase Additional ADSs

GDS Announces Closing of Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs

GDS Announces Closing of Offering of US$550 Million Convertible Senior Notes and Full Exercise of Option to Purchase Additional Notes

GDS to Hold Annual General Meeting on June 26, 2025

GDS Announces the Launch of an Initial Public Offering for its C-REIT on the Shanghai Stock Exchange

GDS Announces Results of Annual General Meeting of Shareholders

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange

GDS Announces Completion of its C-REIT Initial Public Offering on the Shanghai Stock Exchange

Comments

GDS Holdings

Intérêt court

GDS Holdings (NASDAQ:GDS) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL